<DOC>
	<DOC>NCT01618968</DOC>
	<brief_summary>Relative Bioavailability Comparison study</brief_summary>
	<brief_title>Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device</brief_title>
	<detailed_description>A Phase 2, Open-Label, Randomized, 3-Way Crossover Study to Compare the Relative Bioavailability of Oral Methotrexate and the VIBEX™ MTX Device in Adult Subjects With Rheumatoid Arthritis</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Male or female patients ≥18 years of age, diagnosed with Rheumatoid Arthritis Pregnant females Any other clinically significant disease or disorder which, in the opinion of the investigator might put the subject at risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>